EMA committee adopts positive opinion on orphan status for Roche drug The European Medicines Agency announced that the Committee for Orphan Medicinal Products adopted 15 positive opinions recommending the medicines for designation as orphan medicinal products to the European Commission. Among the recommendations, the committee adopted a positive opinion on a mixture of recombinant human IgG1 monoclonal antibodies against human cytomegalovirus envelope glycoproteins for prevention of congenital cytomegalovirus infection following primary cytomegalovirus infection, from Roche. Reference Link
Roche buys nucleic acid purification technology from Lumora Roche has signed a definitive asset purchase agreement with Lumora for products associated with the patent-protected Heat Elution technology for nucleic acid purification of multiple sample types including challenging formalin-fixed paraffin-embedded tumor samples. Roche plans to explore integrating this technology into its sequencing workflow solution.